Inhibikase Therapeutics, Inc. Annual Interest Expense in USD from 2020 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Inhibikase Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2020 to 2021.
  • Inhibikase Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2022 was $0.000, a 100% decline year-over-year.
  • Inhibikase Therapeutics, Inc. annual Interest Expense for 2021 was $19.9K, a 32.2% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $19.9K -$9.48K -32.2% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-31
2020 $29.4K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.